Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/15/2010CN1993362B 稠合的杂环化合物 Fused heterocyclic compound
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1935134B Combination comprising combretastatin and anticancer agents
12/15/2010CN1916009B Process for preparing amine platinum complexes
12/15/2010CN1882567B Quinazoline derivatives as tyrosine kinase inhibitors
12/15/2010CN1857334B Glossy ganoderma spore oil emulsion for intravenous injection and its preparing method
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/15/2010CN1665932B Vectors with modified protease-dependent tropism
12/15/2010CN101918452A Monoclonal antibody capable of binding to Anexelekto, and use thereof
12/15/2010CN101918450A Anti-CLDN6 antibody
12/15/2010CN101918447A Binding molecules to the human OX40 receptor
12/15/2010CN101918442A Anti-VEGF antibodies
12/15/2010CN101918433A Peptides specific for hepatocellular carcinoma cells and applications thereof
12/15/2010CN101918404A 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives
12/15/2010CN101918403A Pyrazolo-pyridines as tyrosine kinase inhibitors
12/15/2010CN101918390A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
12/15/2010CN101918379A Platinum complex compound and utilization of the same
12/15/2010CN101918374A 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
12/15/2010CN101918373A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101918352A Inhibitors of 17beta-hydroxysteroid dehydrogenase
12/15/2010CN101918079A Protein kinase inhibitors and use thereof
12/15/2010CN101918036A Methods for inhibiting fascin
12/15/2010CN101918035A Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent
12/15/2010CN101918034A TAZ/WWTR1 for diagnosis and treatment of cancer
12/15/2010CN101918030A Anti-VEGF antibody compositions and methods
12/15/2010CN101918025A Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ICH) in a selected subpopulation of ich patients
12/15/2010CN101918022A Activin receptor-like kinase-1 compositions and methods of use
12/15/2010CN101918018A Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/15/2010CN101918003A Treatment of uterine cancer and ovarian cancer with a PARP inhibitor alone or in combination with anti-tumor agents
12/15/2010CN101917994A Use of CFMS inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer
12/15/2010CN101917993A Compounds for use in the treatment of cancer
12/15/2010CN101917982A Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
12/15/2010CN101914538A Deoxyribozyme for promoting tumor cell apoptosis
12/15/2010CN101914536A Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof
12/15/2010CN101914533A Interfering rna duplex having blunt-ends and 3'-modifications
12/15/2010CN101914497A Clinical N-CIK cell culture and quality control and identification kit and application
12/15/2010CN101914463A Proteus vulgaris (mannose-sensitive hemagglutination) piliated strain
12/15/2010CN101914458A Candida albicans (mannose protein complex) strain
12/15/2010CN101914168A Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof
12/15/2010CN101914161A Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof
12/15/2010CN101914158A Anti-cd20 antibodies and fusion proteins thereof and methods of use
12/15/2010CN101914135A Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof
12/15/2010CN101914134A Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein
12/15/2010CN101914118A Trehalose derivant and preparation method and application thereof
12/15/2010CN101914117A Dichloroacetoxyl-containing platinum (II) anticancer coordination compound
12/15/2010CN101914095A 2-chloropyridine derivative, preparation method and application thereof to preparation of medicines resistant to liver cancer
12/15/2010CN101914094A 1,3,4-oxadiazole derivative, preparation method and application thereof in preparing antitumor drug
12/15/2010CN101914084A Derivative of diphenylpyrone nitrogen heterocyclic ring as well as preparation method and application thereof
12/15/2010CN101914080A Benzofuran-3-ketone substitute phenyl compound as well as preparation method and application
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/15/2010CN101912620A Application of adenovirus mediated interleukin-24 for preparing radiotherapy hypersitization medicine
12/15/2010CN101912619A Application of ING4 and IL-24 double-gene coexpression vector as radiotherapy sensitizing agent
12/15/2010CN101912618A Preparation method of bone mesenchymal stem cell carrying NK4 gene and application thereof
12/15/2010CN101912615A Cladribine formulations for improved oral and transmucosal delivery
12/15/2010CN101912611A Drug composition with anti-tumor effect
12/15/2010CN101912603A Compound of prostate stem cell antigen and heat shock protein and preparation method and application thereof
12/15/2010CN101912599A Application of recombinant human interleukin 15 in preparing medicament for treating malignant ascitic tumor
12/15/2010CN101912585A Medicament for treating myoma of uterus and preparation method thereof
12/15/2010CN101912582A Traditional Chinese medicine for treating pain caused by liver cancer
12/15/2010CN101912573A Targeted traditional Chinese medicine preparation for treating cancers and preparation method thereof
12/15/2010CN101912544A Chinese patent medicine for treating cancers
12/15/2010CN101912533A Processing technique of dendrobium nobile
12/15/2010CN101912529A Method for extracting total flavones of chloranthus multistachys by using ultrasonic waves
12/15/2010CN101912521A Medicament for treating lung cancer
12/15/2010CN101912514A Paris rhizome total saponin capsules with anti-tumor effect and preparation method thereof
12/15/2010CN101912512A Traditional Chinese medicine decoction for treating nasopharyngeal carcinoma
12/15/2010CN101912465A Preparation method and application of sanguisorba antiphlogistic, analgesic, antiviral and anti-infective dressing
12/15/2010CN101912445A Method for extracting general flavonoids from toona sinensis leaves under assistance of surfactant
12/15/2010CN101912438A Extraction technology of total alkaloids of sophora alopecuroides
12/15/2010CN101912426A Method for preparing ginkgo exocarp anti-tumor effective part and preparation thereof
12/15/2010CN101912425A Ginkgo episperm extract with antitumor and immunostimulating activity and preparation method of effective part thereof
12/15/2010CN101912421A Methods and compositions concerning poxviruses and cancer
12/15/2010CN101912412A Zeolites for delivery of nitric oxide
12/15/2010CN101912400A 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer
12/15/2010CN101912399A Radiotherapy enhancer
12/15/2010CN101912396A Use of hif alpha stabilizers for enhancing erythropoiesis
12/15/2010CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2010CN101912382A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
12/15/2010CN101912377A Application of pterostilbene to preparation of medicament for treating cervical cancer
12/15/2010CN101912369A Method for preparing bendamustine hydrochloride freeze-dried preparation
12/15/2010CN101912366A Degradable gel microspheres interposed in bronchus and application thereof
12/15/2010CN101912362A Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof
12/15/2010CN101912221A Multipurpose traditional Chinese medicine health care drug pillow
12/15/2010CN101560500B Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
12/15/2010CN101450145B Traditional Chinese medicine for treating malignancy and preparation method thereof
12/15/2010CN101362790B Starfish saponins antineoplastic compounds
12/15/2010CN101323634B Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof
12/15/2010CN101318966B Dimerized sesquiterpenoids, preparation and application thereof
12/15/2010CN101244105B Pseudo-ginseng standard extract P1237, its pharmaceutical combination, its preparing method and its uses
12/15/2010CN101244100B Method for preparing extract of shoulder pole tegument and antineoplastic use of the same
12/15/2010CN101230015B Substituted cinnamic acid derivatives containing amine substituent group and tumor cytotoxicity thereof
12/15/2010CN101185671B Anti-tumor medicine extracted from Juglans regia and preparation method thereof
12/15/2010CN101177421B Method for preparing high-purity taxone compounds
12/15/2010CN101102766B Novel derivatives of porphyrin, particularly chlorins and/orbacteriochlorins, and uses thereof in photodynamic therapy
12/15/2010CN101084905B Application of ganoderic acid Me in tumoral growth or propagation inhibitor
12/15/2010CN101054604B Application of oligonucleotide complemented with rna used as transcription product of gene
12/15/2010CN101006999B Therapeutic uses and compositions of isoflavones
12/14/2010US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
1 ... 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 ... 2211